Stocktoria

MANNATECH INC MTEX

Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 1999-02-16

MANNATECH INC statistics & valuation

P / S0.1×

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Gross margin74.9%77.6%78.0%75.9%78.6%
Operating margin-0.4%1.2%-0.7%-0.3%5.7%
Net margin-14.1%2.1%-1.7%-3.3%6.2%
FCF margin-4.0%1.7%-2.4%-2.7%6.3%
Return on assets-50.7%6.9%-5.4%-9.1%16.5%
Return on equity291.3%28.9%-21.4%-31.7%40.3%
Debt / equity-0.53×
Current ratio1.101.251.071.171.42
Revenue growth-8.3%-10.7%-3.8%-14.1%5.5%

Source: SEC EDGAR filings · CIK 0001056358 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.